Aligning with the above-referred studies, EpCAM, CD133, CD90, and CK19 (another hepatic stem marker [95]) were significantly overexpressed in the HCC group and associated with the presence of a corresponding subpopulation of HCC CTCs and with a higher tumor recurrence rate [25]. Here, EPCAM is linked to neoplasm.